Siegfried Schmitt, PhD, is Vice President Technical at Parexel International, Siegfried.Schmitt@parexel.com.
Keeping Audit and Inspection Programs Current
Updating your audits and inspections program ensures inspection preparedness, says Siegfried Schmitt, vice president, Technical at Parexel.
Post-Warning Letter Interaction with FDA
Communication and meetings with FDA after receiving a warning letter demonstrates a serious response, says Siegfried Schmitt, vice president, Technical at Parexel.
Good Manufacturing Practices for Emerging Therapies
Guidance documents and interaction with FDA can help manufacturers stay in GMP compliance, says Siegfried Schmitt, VP Technical, at Parexel.
Phase-appropriate Compliance for Cell and Gene Therapies
Understanding how to apply phase-appropriate GMPs is crucial for achieving successful regulatory approval.
Ensuring Contractors Perform Good Distribution Practices
The license holder should negotiate, educate, contract, and then oversee the transportation contractor, says Siegfried Schmitt, vice president, Technical at Parexel.
Are You Ready for Inspection?
Reviewing regulatory documents, such as 483 forms and Warning Letters, can aid in determining a facility’s inspection readiness, says Siegfried Schmitt, vice president, Technical at Parexel.
Using a Third Party to Perform Audits
There are key elements that should be covered when dealing with third-party auditors, according to Siegfried Schmitt, vice president, Technical, at Parexel.
Clearing Up Confusion in Inspection Terminology
Audits and inspections both assure that requirements have been fulfilled and whether documented proof is available, says Siegfried Schmitt, vice president, Technical at Parexel.
The Inspection Result: Warning Letters and Form 483s
FDA Warning Letters and Form 483s can offer a path to better compliance, says Siegfried Schmitt, vice president, Technical, at Parexel.
Measuring Quality in a Culture
The concept of quality culture and how to enforce it are being debated by regulators and industry, says Siegfried Schmitt, vice president, Technical at Parexel.
Securing the Supply Chain with Good Distribution Practices
Good distribution practices ensure appropriate physical storage, distribution, and supply chain security, says Siegfried Schmitt, vice president, Technical, at Parexel.
Creating a Contamination Control Strategy
A CCS provides significant benefits to the industry and helps with holistically understanding contamination controls, says Siegfried Schmitt, vice president, Technical at Parexel.
Principles of Equipment Qualification
Documentation is crucial to equipment qualification, says Siegfried Schmitt, vice president, Technical at Parexel.
Best Practices for Developing a Third-Party Auditing SOP
A process flow diagram can help create an agreed-upon process flow for a third-party standard operating procedure, says Siegfried Schmitt, VP Technical at Parexel.
The Difference between Electronic Records Retention and Archiving
An SOP for electronic-records archiving is a regulatory requirement and good for business, says Siegfried Schmitt, vice president, Technical at Parexel.
Which Batch Size for Validation and Stability Studies?
Process validation for a drug product must be done with commercial scale batches, says Siegfried Schmitt, vice president, Technical at Parexel.
Remote Inspections - Lessons Learned
This article discusses select industry experience with regulatory authorities utilizing alternative mechanisms for assessing compliance as part of their review and approval of existing marketing authorizations or new applications.
The Importance of Batch Record Reviews During Audits
Auditors must have access to the batch records of the activities they are reviewing, says Siegfried Schmitt, vice president, Technical at Parexel.
Good Manufacturing Practice on Demand?
Siegfried Schmitt, vice president Technical at Parexel, discusses the difficulty of operating non-GMP and GMP quality systems in the same facility.
The Remote Audit–A Tongue-in-Cheek Memo
Siegfried Schmitt, vice president, Technical at Parexel, comments on the new paradigm of remote audits.
Improve Automation, but Beware of the Pitfalls
Siegfried Schmitt, vice president, Technical at Parexel, provides best practices for switching from paper-based to automated processes.
The Value of FDA 483s and Warning Letters
Regulatory inspection reports can be a valuable resource for quality management, according to Siegfried Schmitt, vice president, Technical at Parexel.
Computerized System Descriptions–How Hard Can It Be?
System documentation should include a system description, history, validation information, and references, according to Siegfried Schmitt, Vice President, Technical at Parexel.
Auditing for Good Distribution Practices
Auditing distribution suppliers provides understanding and documentation of the services performed.
Now is the Time to Update the Quality Technical Agreement
Updating the quality technical agreement will clarify any expectations and limitations, says Siegfried Schmitt, vice president, Technical at Parexel.
Resuming Operations During a Pandemic
Siegfried Schmitt, vice president, Technical at Parexel, offers insight into FDA’s guidance on performing operations during COVID-19.
Performing Remote Audits During the Pandemic
It is important to consider the feasibility, benefits, and limitations of each type of audit in advance.
Starting a Career in the Bio/Pharmaceutical Industry
Having a better understanding about compliance will be of benefit when looking for a job or for furthering one’s career, says Siegfried Schmitt, PhD, vice-president, technical, Parexel Consulting.
Embracing Change Management
No matter why change may be needed, it is important to comply with all the relevant regulatory requirements, says Siegfried Schmitt, PhD, vice-president, technical, Parexel Consulting.
Signatures–What’s in a Name?
It is good industry practice to clarify the precise remit for each of the reviewers of a controlled document, says Siegfried Schmitt, PhD, vice-president, technical, Parexel Consulting.